Asuragen is seeking an outstanding Ph.D.-level scientist who can work as part of a Research group that conceives and creates innovative amplification-based technologies for the detection of nucleic acid and/or protein biomarkers. This high-impact position will help expand our molecular diagnostics portfolio that currently influences over 15 million patient management decisions each year.
The Senior Scientist position requires scientific creativity, independence, and technical leadership within our R&D team to conceptualize and develop sample-to-answer workflows for nucleic acid-based tests. This role will help enable novel multiplexed PCR assays that can resolve DNA, RNA, and/or protein biomarkers, including emerging markers. Assays are designed using rapid and streamlined methods that can be broadly deployed in kitted diagnostic products, and integrate reagents, instrumentation, and analysis algorithms and software. Additional responsibilities for the position include managing scientific collaborations, leading grant applications, writing peer-reviewed manuscripts, and sparking new patent applications. Successful candidates will join a fast-growing company of nearly 150 employees focused on enhancing patient care through the development of cutting-edge diagnostic assays in disease areas spanning genetic disorders and cancer.
- A Ph.D. degree in biology, biochemistry, chemistry, biomedical engineering, or related field
- Expertise in multiple technologies/fields, including innovative and ideally highly multiplexed PCR methods, and the ability to combine insights from different disciplines to leap technical barriers
- A strong track record of independence, innovation, and productivity through multiple peer-reviewed publications and/or patents
- Successful project outcomes through internal and external collaborations
- Excellent written and verbal communication skills
- Ability to analyze complex data with relevant statistical methods and clearly present information to technical and non-technical audiences
- A passion for improving patient care through diagnostic technologies, particularly in genetics and oncology